Genzyme Renal Innovations Program

The Genzyme Renal Innovations Program (GRIP) distributes grants to researchers, clinicians and fellows in the field of nephrology. GRIP was established to support the advancement of medical knowledge and practice in kidney diseases through innovative research projects in nephrology.

A maximum of ten grants are awarded each year, with funding available for up to a maximum of $50,000 USD per year for a period of 1 to 3 years. Each year a different independent medical review board composed of worldwide thought leaders in the nephrology community assesses and scores all proposals.

In addition to the scientific merit of the proposed research, the medical review board considers the following criteria:

  • Innovation of the proposal
  • Clinical importance and potential impact
  • Adequacy of the experimental design
  • Qualifications and experience of the principal investigator for the proposed research
  • Feasibility of the budget and duration of the proposed research

ISN entered into a partnership on Genzyme’s Renal Innovations Program (GRIP) whereby ISN has agreed to disseminate the results of GRIP-supported projects through its range of communications channels.

For more information on the GRIP program or for application details please visit www.renagel.com or send an email to [email protected].

 

Extra navigation

Advertisement